ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway

Lu, Yaru; Ma, Qian; Yu, Lu; Huang, Huan; Liu, Xiaoxi; Chen, Pei; Ran, Hao*; Liu, Weibin*南方医科大学; 中山大学; 1
International Immunopharmacology2023-2DOI: 10.1016/j.intimp.2023.109693
4被引6阅读
引用收藏
分享

摘要

Background: An imbalance in Th17/regulatory T (Treg) cells is the major pathogenic mechanism underlying myasthenia gravis (MG). JAK2 inhibitors selectively inhibit JAK2 and reduce inflammatory responses. However, there have been no studies examining the therapeutic effects of JAK2 inhibitors in the context of MG.Methods: Here, an experimental autoimmune MG (EAMG) rat model was established to explore the therapeutic effect of JAK2 inhibitors on EAMG rats immunized with the AChR alpha-subunit (97-116 peptide). A JAK2 inhibitor was administered to EAMG rats both in vivo and in vitro. The following experimental methods were used to evaluate the effects of JAK2 inhibitors. The behavioral scores and body weights of the rats were assessed on alternate days. Serum anti-AChR (97-116) IgG and cytokine levels were detected using ELISA. CD4+ T cell subsets and related transcription factors in mononuclear cells were detected using flow cytometry and qPCR, respectively. The expression levels of protein molecules in the signaling pathway were detected by western blotting, and the neuromuscular junctions were observed using immunofluorescence.Results: The results revealed that JAK2 inhibitors could regulate Th17/Treg balance in vivo and in vitro. JAK2 inhibitors reduced the immune response in EAMG rats (including reducing pro-inflammatory cytokines and postsynaptic membrane complement deposition), improved clinical symptoms, and increased AChR aggregation in the postsynaptic membrane. Meanwhile, this study demonstrated that JAK2 inhibitor treatment suppressed the phosphorylation of JAK2/STAT3 and AKT/mTOR pathways and decreased the expression level of the IL-23 receptor.Conclusions: This study reveals that there is crosstalk between the JAK2/STAT3 and AKT/mTOR pathways in EAMG rats. JAK2 inhibitors can ameliorate EAMG by regulating Th17/Treg balance by inhibiting both signaling pathways. Our study provides new potential therapeutic targets for MG immunotherapy.

学科与关键词

关键词
JAK2 inhibitorExperimental autoimmune myasthenia gravisTh17Treg balance
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2023-02
卷期
第 115 卷
页码
109693
DOI
10.1016/j.intimp.2023.109693
语言
ENGLISH
成果收录
SCIE
资助标注
Key International Cooperative research Project of National Natural Science Foundation of China [81620108010]; National Natural Science Foundation of China [81873772, 81971754]; Clinical Study of 5010 Planned Project Sun Yat-sen University [2010003]; Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases [2020B1212060017]; Guangdong Provincial Clinical Research Center for Neurological Diseases [2020B1111170002]; Southern China International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases [2015B050501003, 2020A0505020004]

作者

  • L

    Lu, Yaru (第一作者)

  • M

    Ma, Qian

    1 · 2 · sun yat sen univ

查看全部 8 位作者收起作者
  • Y

    Yu, Lu

  • H

    Huang, Huan

    capital med univ

  • L

    Liu, Xiaoxi

    southern med univ

  • C

    Chen, Pei

    1 · 2 · sun yat sen univ

  • R

    Ran, Hao (通讯)

    sun yat sen univ

  • L

    Liu, Weibin (通讯)

    1 · 2 · sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417